GWWClass I

Ataxiagraph

21 CFR 882.1030 / Neurology

GWW is the FDA product code for Ataxiagraph, a class I device type, regulated under 21 CFR 882.1030. FDA's definition for this code reads: "Exemption is limited to devices that do not provide an interpretation or a clinical implication of the measurement". As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: GWW
Device name: Ataxiagraph
FDA definition: Exemption is limited to devices that do not provide an interpretation or a clinical implication of the measurement.
Regulation: 21 CFR 882.1030
Device class: Class I
Review panel: Neurology
Submission type: 510(k) exempt
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

Recent clearances

Product code GWW

FDA records hold no clearances under product code GWW.

Recent recalls

Product code GWW

FDA records show no recalls under product code GWW.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)